These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3447914)

  • 21. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Coker LD; Turnbull TA; Morita ET
    J Clin Invest; 1989 Oct; 84(4):1220-5. PubMed ID: 2794058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gallbladder contraction: effects of fatty meals and cholecystokinin.
    Hopman WP; Rosenbusch G; Jansen JB; de Jong AJ; Lamers CB
    Radiology; 1985 Oct; 157(1):37-9. PubMed ID: 3898222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gallbladder motility after duodenum-preserving resection of the head of the pancreas.
    Eddes EH; Masclee AM; Gielkens HA; Gooszen HG; Lamers CB
    Scand J Gastroenterol; 1997 Sep; 32(9):878-83. PubMed ID: 9299664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of cholecystokinin-induced gallbladder contraction by atropine and pirenzepine in man.
    Yegen BC; Tankurt E; Gürmen N; Bayram M; Oktay S; Ulusoy NB
    Digestion; 1990; 45(3):176-80. PubMed ID: 2373273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vagal influence on cholecystokinin and neurotensin release in conscious dogs.
    Schafmayer A; Nustede R; Pompino A; Köhler H
    Scand J Gastroenterol; 1988 Apr; 23(3):315-20. PubMed ID: 3387897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of circulating peptide YY on gallbladder emptying in humans.
    Hoentjen F; Hopman WP; Jansen JB
    Scand J Gastroenterol; 2001 Oct; 36(10):1086-91. PubMed ID: 11589384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of loxiglumide and atropine on erythromycin-induced reduction in gallbladder volume in human subjects.
    Jebbink MC; Masclee AA; van der Kleij FG; Schipper J; Rovati LC; Jansen JB; Lamers CB
    Hepatology; 1992 Oct; 16(4):937-42. PubMed ID: 1398500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of equimolar amounts of long-chain triglycerides and medium-chain triglycerides on plasma cholecystokinin and gallbladder contraction.
    Hopman WP; Jansen JB; Rosenbusch G; Lamers CB
    Am J Clin Nutr; 1984 Mar; 39(3):356-9. PubMed ID: 6695835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of cholecystokinin in man: correlation of blood levels with gallbladder contraction.
    Wiener I; Inoue K; Fagan CJ; Lilja P; Watson LC; Thompson JC
    Ann Surg; 1981 Sep; 194(3):321-7. PubMed ID: 7271349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
    Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR
    Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of cisapride on gallbladder emptying and pancreatic polypeptide and cholecystokinin release in humans.
    Meguro T; Shimosegawa T; Kikuchi Y; Koizumi M; Toyota T
    J Gastroenterol; 1995 Apr; 30(2):237-43. PubMed ID: 7773354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholinergic dependence of gallbladder response to cholecystokinin in the guinea pig in vivo.
    Takahashi T; May D; Owyang C
    Am J Physiol; 1991 Oct; 261(4 Pt 1):G565-9. PubMed ID: 1681736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gallbladder emptying response to sham feeding in humans.
    Fisher RS; Rock E; Malmud LS
    Gastroenterology; 1986 Jun; 90(6):1854-7. PubMed ID: 2870951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of lorglumide and atropine on MgSO(4)-induced gallbladder emptying in conscious dogs.
    Sterczer A; Szénási G; Vörös K; Pap A
    Res Vet Sci; 2000 Oct; 69(2):129-33. PubMed ID: 11020363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of aging on gallbladder contraction and release of cholecystokinin-33 in humans.
    Khalil T; Walker JP; Wiener I; Fagan CJ; Townsend CM; Greeley GH; Thompson JC
    Surgery; 1985 Sep; 98(3):423-9. PubMed ID: 4035564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of cholecystokinin in postprandial and vagally stimulated duodenal and gallbladder motility in dogs.
    Thor P; Laskiewcz J; Maczka M; Konturek SJ
    J Physiol Pharmacol; 1991 Dec; 42(4):381-8. PubMed ID: 1824297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastric lipase secretion after sham feeding and cholinergic blockade.
    Wøjdemann M; Olsen O; Nørregaard P; Sternby B; Rehfeld JF
    Dig Dis Sci; 1997 May; 42(5):1070-5. PubMed ID: 9149064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between gallbladder size and release of cholecystokinin after oral magnesium sulfate in man.
    Inoue K; Wiener I; Fagan CJ; Watson LC; Thompson JC
    Ann Surg; 1983 Apr; 197(4):412-5. PubMed ID: 6830347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mu-Opiate receptor agonist loperamide blocks bethanechol-induced gallbladder contraction, despite higher cholecystokinin plasma levels in man.
    Otto B; Mawe GM; Riepl RL
    Neurogastroenterol Motil; 2005 Oct; 17(5):761-6. PubMed ID: 16185316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intravenous fat on cholecystokinin secretion and gallbladder motility in man.
    de Boer SY; Masclee AA; Jebbink MC; Schipper J; Jansen JB; Lamers CB
    JPEN J Parenter Enteral Nutr; 1992; 16(1):16-9. PubMed ID: 1738213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.